Source:http://linkedlifedata.com/resource/pubmed/id/10201643
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0003695,
umls-concept:C0013030,
umls-concept:C0021467,
umls-concept:C0021469,
umls-concept:C0030685,
umls-concept:C0070750,
umls-concept:C0082341,
umls-concept:C0085080,
umls-concept:C0205184,
umls-concept:C0205263,
umls-concept:C0231491,
umls-concept:C0391871,
umls-concept:C0662820,
umls-concept:C0680255,
umls-concept:C1283071,
umls-concept:C1963578
|
pubmed:issue |
11
|
pubmed:dateCreated |
1999-4-21
|
pubmed:abstractText |
In Chinese hamster ovary (CHO) cells transfected with the cDNA for the dopamine D3 receptor, low concentrations of dopamine (IC50: 0.5 nM) counteracted the release of arachidonic acid (AA) induced by the protein kinase C activator TPA (maximal inhibition: 15% at 10 - 30 nM). The effect of dopamine -- which was antagonized by pretreatment with pertussis toxin (PTX) or by the dopamine receptor antagonist haloperidol -- was biphasic; thus, at increasing concentrations of dopamine (100 nM - 1 microM), AA levels approached baseline. The preferential dopamine D3 receptor ligand PNU-99194A displayed an effect similar to that of dopamine; thus, whereas low concentrations of PNU-99194A (IC50: 1.9 nM) reduced TPA-induced AA release (maximal inhibition: 15% at 30 - 100 nM), higher concentrations (> or =1 microM) were ineffective. When dopamine and PNU-99194A were administered together at concentrations yielding maximal inhibition of AA release, no additive effect was observed; moreover, a high concentration of dopamine counteracted the AA-reducing effect of a low concentration of PNU-99194A and vice versa. It is suggested that D3 receptors in transfected CHO cells may exert mainly an inhibitory, but also a stimulatory influence on TPA-induced AA release, and that PNU-99194A acts as an agonist in this system.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/(5,6-dimethoxyindan-2-yl)dipropylami...,
http://linkedlifedata.com/resource/pubmed/chemical/Arachidonic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Dopamine Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Indans,
http://linkedlifedata.com/resource/pubmed/chemical/Pertussis Toxin,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Dopamine D2,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Dopamine D3,
http://linkedlifedata.com/resource/pubmed/chemical/Tetradecanoylphorbol Acetate,
http://linkedlifedata.com/resource/pubmed/chemical/Virulence Factors, Bordetella
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0024-3205
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
64
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
939-51
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10201643-Animals,
pubmed-meshheading:10201643-Arachidonic Acid,
pubmed-meshheading:10201643-CHO Cells,
pubmed-meshheading:10201643-Cricetinae,
pubmed-meshheading:10201643-Dopamine,
pubmed-meshheading:10201643-Dopamine Antagonists,
pubmed-meshheading:10201643-Indans,
pubmed-meshheading:10201643-Pertussis Toxin,
pubmed-meshheading:10201643-Receptors, Dopamine D2,
pubmed-meshheading:10201643-Receptors, Dopamine D3,
pubmed-meshheading:10201643-Tetradecanoylphorbol Acetate,
pubmed-meshheading:10201643-Transfection,
pubmed-meshheading:10201643-Virulence Factors, Bordetella
|
pubmed:year |
1999
|
pubmed:articleTitle |
Both dopamine and the putative dopamine D3 receptor antagonist PNU-99194A induce a biphasic inhibition of phorbol ester-stimulated arachidonic acid release from CHO cells transfected with the dopamine D3 receptor.
|
pubmed:affiliation |
Department of Pharmacology, Institute of Physiology and Pharmacology, Göteborg University, Sweden. neuroendo@pharm.gu.se
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|